Cargando…
A RETROSPECTIVE CASE CONTROL STUDY TO ASSESS THE EFFECTIVENESS OF BARICITINIB AMONG MODERATE TO SEVERE COVID-19 CASES; EXPERIENCE FROM A SOUTH INDIAN TERTIARY CARE CENTRE
INTRO: Dysregulated inflammation plays a key role in the development of severe SARS-CoV-2 infection. One of the key cellular signaling pathway involved in the inflammatory response is JAK/STAT signaling. Among the hospitalized Covid patients with hypoxia to reduce the progression to ARDS, immunomodu...
Autores principales: | Kambhampati, N.T., Sathyapalan, D., Moni, M., Pillai M, G., Moosa, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186899/ http://dx.doi.org/10.1016/j.ijid.2023.04.213 |
Ejemplares similares
-
Myocardial injury after noncardiac surgery—incidence and predictors from a prospective observational cohort study at an Indian tertiary care centre
por: George, Rubin, et al.
Publicado: (2018) -
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022) -
Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022) -
Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
por: Titanji, Boghuma K, et al.
Publicado: (2020) -
NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
Publicado: (2021)